======= LHX3 =======
== Gene Information ==
* **Official Symbol**: LHX3
* **Official Name**: LIM homeobox 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8022|8022]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBR4|Q9UBR4]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LHX3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LHX3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600577|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of a large family of proteins which carry the LIM domain, a unique cysteine-rich zinc-binding domain. The encoded protein is a transcription factor that is required for pituitary development and motor neuron specification. Mutations in this gene cause combined pituitary hormone deficiency 3. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015].
* **UniProt Summary**: Acts as a transcriptional activator. Binds to and activates the promoter of the alpha-glycoprotein gene, and synergistically enhances transcription from the prolactin promoter in cooperation with POU1F1/Pit-1 (By similarity). Required for the establishment of the specialized cells of the pituitary gland and the nervous system. Involved in the development of interneurons and motor neurons in cooperation with LDB1 and ISL1. {ECO:0000250, ECO:0000269|PubMed:21149718}.
|LIM|
|Homeobox|
|medial motor column neuron differentiation|
|somatic motor neuron differentiation|
|cell fate specification involved in pattern specification|
|ventral spinal cord interneuron specification|
|spinal cord motor neuron cell fate specification|
|spinal cord association neuron differentiation|
|ventral spinal cord interneuron fate commitment|
|cell fate commitment involved in pattern specification|
|ventral spinal cord interneuron differentiation|
|spinal cord dorsal/ventral patterning|
|dorsal spinal cord development|
|spinal cord patterning|
|motor neuron axon guidance|
|neuron fate specification|
|spinal cord motor neuron differentiation|
|pituitary gland development|
|ventral spinal cord development|
|cell differentiation in spinal cord|
|RNA polymerase II transcription factor binding|
|neuron fate commitment|
|diencephalon development|
|dorsal/ventral pattern formation|
|cell fate specification|
|spinal cord development|
|endocrine system development|
|placenta development|
|lung development|
|respiratory tube development|
|central nervous system neuron differentiation|
|inner ear development|
|respiratory system development|
|transcription factor complex|
|ear development|
|cell fate commitment|
|axon guidance|
|neuron projection guidance|
|RNA polymerase II regulatory region sequence-specific DNA binding|
|regionalization|
|axonogenesis|
|forebrain development|
|axon development|
|gland development|
|sequence-specific DNA binding|
|reproductive structure development|
|reproductive system development|
|cell morphogenesis involved in neuron differentiation|
|pattern specification process|
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|neuron projection morphogenesis|
|plasma membrane bounded cell projection morphogenesis|
|cell projection morphogenesis|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|cell part morphogenesis|
|sensory organ development|
|chemotaxis|
|taxis|
|cell morphogenesis involved in differentiation|
|neuron projection development|
|developmental process involved in reproduction|
|cell morphogenesis|
|brain development|
|head development|
|neuron development|
|cellular component morphogenesis|
|tube development|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|animal organ morphogenesis|
|central nervous system development|
|negative regulation of cell death|
|neuron differentiation|
|plasma membrane bounded cell projection organization|
|cell projection organization|
|positive regulation of transcription by RNA polymerase II|
|locomotion|
|reproductive process|
|reproduction|
|generation of neurons|
|regulation of apoptotic process|
|positive regulation of transcription, DNA-templated|
|movement of cell or subcellular component|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|regulation of programmed cell death|
|neurogenesis|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|cell development|
|regulation of cell death|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15152
* **Expression level (log2 read counts)**: -2.21
{{:chemogenomics:nalm6 dist.png?nolink |}}